Related Experiment Video
Updated: Jun 25, 2026
08:58
En Face Detection of Nitric Oxide and Superoxide in Endothelial Layer of Intact Arteries
Published on: February 25, 2016
Nitric oxide, NAD(P)H oxidase, and atherosclerosis
Gregor Muller1, Henning Morawietz
1Department of Vascular Endothelium and Microcirculation, University of Technology Dresden, Dresden, Germany.
Antioxidants & Redox Signaling
|March 5, 2009
Summary
Atherosclerosis involves endothelial dysfunction where nitric oxide (NO) is depleted by reactive oxygen species from NAD(P)H oxidases. Restoring the NO/superoxide balance is key for cardiovascular disease therapies.
Area of Science:
- Vascular Biology
- Cardiovascular Research
- Biochemistry
Background:
- Endothelial cells are crucial in atherosclerosis development.
- Endothelial NO synthase (eNOS) produces nitric oxide (NO), vital for vasodilation.
- Reactive oxygen species (ROS), particularly from NAD(P)H oxidases, reduce NO availability and promote inflammation.
Purpose of the Study:
- To review the structure and regulation of NAD(P)H oxidase complexes.
- To examine the modulation of the NO/superoxide anion balance by various factors.
- To summarize the role of NO and NAD(P)H oxidase-derived ROS in atherosclerosis.
Main Methods:
- Literature review focusing on NAD(P)H oxidase complexes.
- Analysis of factors influencing the vascular NO/superoxide balance.
- Synthesis of recent findings on NO and ROS in atherosclerosis.
Main Results:
- NAD(P)H oxidases are significant ROS sources in the vessel wall.
- ROS can uncouple eNOS, shifting production from NO to superoxide.
- Hemodynamic forces, vasoconstrictors, and oxidized LDL impact the NO/superoxide balance.
Conclusions:
- The balance between NO and superoxide anions is critical in cardiovascular health.
- Understanding NAD(P)H oxidases and ROS is essential for atherosclerosis research.
- Targeting mechanisms that restore the vascular NO/superoxide balance offers therapeutic potential for cardiovascular diseases.
Related Concept Videos
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...